为克服急性髓性白血病CAR-T细胞治疗障碍的发展战略
Chanukya K Colonne1, Erik L Kimble2,3, Cameron J Turtle1,4
1Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Expert review of hematology
|October 23, 2024
概括
卡尔-T细胞疗法对复发性/耐药性急性髓性白血病 (AML) 有前途. 克服有限的目标和瘤微环境等挑战是 AML 持续缓解的关键.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 血液学 血液学 血液学
背景情况:
- 复发性/耐药性急性髓性白血病 (R/RAML) 存在重大治疗挑战.
- 化学抗原受体 (CAR) -T细胞疗法是R/RAML的新兴治疗方法.
研究的目的:
- 审查阻碍在R/RAML中成功进行CAR-T细胞免疫治疗的障碍.
- 讨论科学进步和克服这些障碍的战略.
主要方法:
- 对R/RAML中CAR-T细胞疗法的临床试验数据的审查.
- 分析关键挑战,包括瘤向抗原稀缺,T细胞缺陷和瘤微环境.
主要成果:
- 在R/RAML中,CAR-T细胞疗法已经显示出完全反应的潜力.
- 响应的持久性和重大障碍仍然是关键考虑因素.
结论:
- 在R/R AML中持续缓解需要多方面的方法.
- 目标抗原选择,CAR-T细胞质量以及克服瘤微环境方面的进展至关重要.
相关概念视频
Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K


